PaxMedica, Inc.
PXMD
$0.00
$0.000.00%
OTC PK
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -48.22% | -54.84% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -70.39% | -18.74% | |||
| Operating Income | 70.39% | 18.74% | |||
| Income Before Tax | 70.76% | 18.83% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 70.76% | 18.83% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 70.76% | 18.83% | |||
| EBIT | 70.39% | 18.74% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 75.28% | 21.33% | |||
| Normalized Basic EPS | 75.28% | 21.37% | |||
| EPS Diluted | 75.28% | 21.68% | |||
| Normalized Diluted EPS | 75.28% | 21.37% | |||
| Average Basic Shares Outstanding | 18.30% | 3.20% | |||
| Average Diluted Shares Outstanding | 18.30% | 3.20% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||